European Archives - Page 806 of 994 - European Medical Journal

Promising Results from Phase II Trial of Renal Cancer Drug

RESULTS published from a Phase II clinical trial have shown the potential of the investigational drug savolitinib in the treatment of c-MET-driven…

RedHill Biopharma Announces First Patient Dosed in the Open-Label Extension Study to the Phase III Study with RHB-104 for Crohn’s Disease

Tel-Aviv, Israel, March 21, 2017 – RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty…

WIRED Health 2017: Innovation on a Global Scale

One of the most exciting events for medical innovation in the UK, WIRED Health took place this year on 9th March with a packed agenda bursting with…

The First Successful Robot-Assisted Retinal Vein Cannulation

A REVOLUTIONARY treatment has been developed for the surgical dispersal of retinal vein occlusion clots. The procedure would not have been possible…

Scientists Develop Bioprinting Technology Capable of Synthesising Human Skin

HUMAN skin has been successfully synthesised using a three-dimensional (3D) bioprinter. Researchers at the Universidad Carlos III de Madrid, Madrid…

Selvita Announces First Patient Dosed in Phase I/II Clinical Trial of SEL24 in Acute Myeloid Leukemia

Kraków, Poland, March 17, 2017 – Selvita (WSE:SLV), a clinical stage drug discovery and development company focused on innovative medicines for patients…

Genomic Health Unveils a Wealth of Data for the Oncotype DX® Breast Cancer Test, Reinforcing Its Value in Improving Patient Outcomes and Leading to More Cost-Effective Management

Geneva, Switzerland, March 17, 2017 – Genomic Health today announced the presentation of 15 abstracts for the Oncotype DX® breast cancer test at the 15th…

Agena Bioscience Introduces New Lung and Colon Cancer Panels for Detection of Somatic Mutations from Liquid Biopsies and Solid Tumor Tissues

Agena Bioscience today introduced new targeted research panels for the detection of somatic mutations from lung and colon cancers.

Cambridge-based Astex Pharmaceuticals Celebrates as Cancer Drug Receives US Marketing Approval

Cambridge, UK, March 13, 2017 – Astex Pharmaceuticals (“Astex”), a pharmaceutical company dedicated to the discovery and development of novel small…

Selvita to Present New Data from its Oncology Programs at the Upcoming AACR Annual Meeting 2017

Kraków, Poland, March 13, 2017 – Selvita (WSE:SLV), a clinical stage drug discovery and development company focused on innovative medicines for oncology…